|
|
|
|
|
|
|
|
|
|
Note: this adverse effect has been known for many years (risk vs benefit)
Highlights
► Secondary myeloid leukemia after epithelial ovarian cancer is a rare event.
► It is highly lethal. ► Its incidence has decreased since use of platinum/taxane-based regimens.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.